Literature DB >> 17913171

Pars planitis in children: epidemiologic, clinical, and therapeutic characteristics.

Ricardo Romero1, Jesus Peralta, Elena Sendagorta, Jose Abelairas.   

Abstract

PURPOSE: To report the demographics and clinical characteristics, therapy logarithm, and prognosis of children with pars planitis. PATIENTS AND METHODS: The medical records were reviewed of all patients diagnosed with pars planitis between June 1995 and December 2005 in the Department of Pediatric Ophthalmology at Hospital Universitario La Paz, Madrid, Spain. A retrospective, descriptive, and longitudinal study of 30 eyes in 16 children was performed.
RESULTS: Pars planitis was bilateral in 87.5% and more frequent in males (68.8%). Average age at onset was 9.2 years. The main ophthalmologic findings recorded were snowballs (96.7%) and vitritis (93.3%). Cataract formation was the most prevalent complication (36.7%). Mean initial and final best-corrected visual acuities were 0.640 and 0.840, respectively. Periocular corticosteroids were used in 33.3% of cases and cryotherapy or laser photocoagulation in 16.7%. Complications requiring surgical management occurred in 4 eyes (13.3%).
CONCLUSION: Pars planitis treated with adequate medical and surgical procedures has a good prognosis in most cases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17913171

Source DB:  PubMed          Journal:  J Pediatr Ophthalmol Strabismus        ISSN: 0191-3913            Impact factor:   1.402


  9 in total

1.  Spectral domain optical coherence tomography findings of patients with pars planitis and risk factors affecting visual acuity.

Authors:  F Nilüfer Yalçındağ; Emine Temel; Emrah Gökay Özgür
Journal:  Int Ophthalmol       Date:  2021-02-09       Impact factor: 2.031

2.  Analysis of clinical features and visual outcomes of pars planitis.

Authors:  Nilufer Berker; Emine Sen; Ufuk Elgin; Cemile Ucgul Atilgan; Erdem Dursun; Pelin Yilmazbas
Journal:  Int Ophthalmol       Date:  2017-04-07       Impact factor: 2.031

3.  Use of Immunosuppressive Medications for Treatment of Pediatric Intermediate Uveitis.

Authors:  Aimee O Hersh; Spencer Cope; John F Bohnsack; Akbar Shakoor; Albert T Vitale
Journal:  Ocul Immunol Inflamm       Date:  2016-12-14       Impact factor: 3.070

Review 4.  Current perspectives on ophthalmic manifestations of childhood rheumatic diseases.

Authors:  Neal V Palejwala; Steven Yeh; Sheila T Angeles-Han
Journal:  Curr Rheumatol Rep       Date:  2013-07       Impact factor: 4.592

5.  Pediatric uveitis.

Authors:  Ilknur Tugal-Tutkun
Journal:  J Ophthalmic Vis Res       Date:  2011-10

6.  Four years old, one eye, pars planitis and cataract: surgical challenges give challenging surprises.

Authors:  Leonardo García-Rojas; Humberto Matiz-Moreno; Eduardo Chávez-Mondragón
Journal:  Case Rep Ophthalmol       Date:  2013-03-06

7.  Childhood pars planitis; clinical features and outcomes.

Authors:  Homayoon Nikkhah; Alireza Ramezani; Hamid Ahmadieh; Masoud Soheilian; Mohsen Azarmina; Mohammad-Hossein Dehghan; Siamak Moradian; Ramin Nourinia
Journal:  J Ophthalmic Vis Res       Date:  2011-10

Review 8.  Pars Planitis: Epidemiology, Clinical Characteristics, Management and Visual Prognosis.

Authors:  Pinar Cakar Ozdal; Nilufer Berker; Ilknur Tugal-Tutkun
Journal:  J Ophthalmic Vis Res       Date:  2015 Oct-Dec

9.  Challenges with cataract surgery in pars planitis patients.

Authors:  Andrzej Grzybowski; Piotr Kanclerz; Uwe Pleyer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-06-07       Impact factor: 3.117

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.